Japan, Sept. 16 -- GENENTECH INC,F HOFFMANN-LA ROCHE AG has got intellectual property rights for 'METHODS FOR TREATING EXACERBATION OF INFLAMMATORY RESPIRATORY DISEASES.' Other related details are as follows:
Application Number: JP,2024-122651
Category (FI): A61K45/00,A61K31/573,A61K31/522,A61P11/00,A61K39/395@N,G01N33/92@Z
Stage: PROBLEM TO BE SOLVED: To provide: therapeutic methods for the treatment of exacerbation of inflammatory respiratory diseases, including chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), and asthma; in particular, methods for patient selection, diagnosis and treatment; and methods for preparing and analyzing lysophosphatidic acid (LPA) samples.SOLUTION: The level of one or more of lysophosphatidic acid (LPA) 16:0, LPA18:0, LPA18:1, LPA18:2 and LPA20:4 in a sample from a patient is measured.SELECTED DRAWING: None (Grant)
Filing Date: July 29, 2024
Publication Date: Nov. 13, 2024
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
